SCHEMBL7175105

SCHEMBL7175105

CNC(=O)C(NC(=O)C(Nc1ccc(-c2ccccc2)cc1)C(O)C(=O)NO)C(C)(C)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FCER2 P06734 1/20 0.40
ADAM17 P78536 7/20 0.40
MMP3 P08254 7/20 0.40
MMP2 P08253 7/20 0.40
MMP1 P03956 6/20 0.40
TNF P01375 2/20 0.40
MMP9 P14780 4/20 0.37
MMP8 P22894 3/20 0.37
MMP7 P09237 2/20 0.37
MMP14 P50281 2/20 0.37
MMP20 O60882 1/20 0.37
ADAMTS4 O75173 1/20 0.37
MMP10 P09238 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MMP15 P51511 1/20 0.37
MMP16 P51512 1/20 0.37
MMP25 Q9NPA2 1/20 0.37
MMP26 Q9NRE1 1/20 0.37
ADAMTS5 Q9UNA0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7172633 0.90 FCER2 (0.41) FCER2ADAM17MMP3MMP2MMP1
SCHEMBL7174032 0.89 ADAM17 (0.50) FCER2ADAM17MMP3MMP2MMP1
SCHEMBL7174678 0.86 MMP1 (0.47) MMP3MMP2MMP1MMP9MMP7
SCHEMBL7170637 0.83 ALOX15 (0.45) MMP3MMP2MMP1MMP8MMP13
SCHEMBL7172616 0.82 MMP3 (0.46) FCER2ADAM17MMP3MMP2MMP1
SCHEMBL7170096 0.80 FCER2 (0.50) FCER2ADAM17MMP3MMP2MMP1
SCHEMBL7174311 0.79 MMP3 (0.48) MMP3MMP1MMP9
SCHEMBL7173722 0.77 FCER2 (0.57) FCER2ADAM17MMP3MMP2MMP1
SCHEMBL7192046 0.76 MMP3 (0.52) FCER2ADAM17MMP3MMP2MMP1
SCHEMBL7174038 0.74 TAAR1 (0.39) FCER2MMP3MMP2MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576628-B1 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis ROCHE DIAGNOSTICS GMBH (DE) 2003-06-10 US disclosed
EP-1005449-B1 3-ARYL-SUCCINAMIDO-HYDROXAMIC ACIDS, METHODS FOR PRODUCING SAID ACIDS AND MEDICAMENTS CONTAINING THE SAME ROCHE DIAGNOSTICS GMBH (DE) 2002-10-30 EP disclosed
EP-0897908-A1 3-Aryl-succinamido-hydroxamic acids, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1999-02-24 EP disclosed